BACKGROUND: Fluorescence-based enhanced reality (FLER) is a technique to evaluate intestinal perfusion based on the elaboration of the Indocyanine Green fluorescence signal. The aim of the study was to assess FLER's performances in evaluating perfusion in an animal model of long-lasting intestinal ischemia. MATERIALS AND METHODS: An ischemic segment was created in 18 small bowel loops in 6 pigs. After 2 h (n = 6), 4 h (n = 6), and 6 h (n = 6), loops were evaluated clinically and by FLER to delineate five regions of interest (ROIs): ischemic zone (ROI 1), presumed viable margins (ROI 2a-2b), and vascularized areas (3a-3b). Capillary lactates were measured to compare clinical vs. FLER assessment. Basal (V 0 ) and maximal (V max) mitochondrial respiration rates were determined according to FLER. RESULTS: Lactates (mmol/L) at clinically identified resection lines were significantly higher when compared to those identified by FLER (2.43 ± 0.95 vs. 1.55 ± 0.33 p = 0.02) after 4 h of ischemia. Lactates at 2 h at ROI 1 were 5.45 ± 2.44 vs. 1.9 ± 0.6 (2a-2b; p < 0.0001) vs. 1.2 ± 0.3 (3a-3b; p < 0.0001). At 4 h, lactates were 4.36 ± 1.32 (ROI 1) vs. 1.83 ± 0.81 (2a-2b; p < 0.0001) vs. 1.35 ± 0.67 (3a-3b; p < 0.0001). At 6 h, lactates were 4.16 ± 2.55 vs. 1.8 ± 1.2 vs. 1.45 ± 0.83 at ROI 1 vs. 2a--2b (p = 0.013) vs. 3a-3b (p = 0.0035). Mean V 0 and V max (pmolO2/second/mg of tissue) were significantly impaired after 4 and 6 h at ROI 1 (V 0 (4h) = 34.83 ± 10.39; V max (4h) = 76.6 ± 29.09; V 0 (6h) = 44.1 ± 12.37 and V max (6h) = 116.1 ± 40.1) when compared to 2a--2b (V 0 (4h) = 67.1 ± 17.47 p = 0.00039; V max (4h) = 146.8 ± 55.47 p = 0.0054; V 0 (6h) = 63.9 ± 28.99 p = 0.03; V max (6h) = 167.2 ± 56.96 p = 0.01). V 0 and V max were significantly higher at 3a-3b. CONCLUSIONS: FLER may identify the future anastomotic site even after repetitive assessments and long-standing bowel ischemia.
BACKGROUND: Fluorescence-based enhanced reality (FLER) is a technique to evaluate intestinal perfusion based on the elaboration of the Indocyanine Green fluorescence signal. The aim of the study was to assess FLER's performances in evaluating perfusion in an animal model of long-lasting intestinal ischemia. MATERIALS AND METHODS: An ischemic segment was created in 18 small bowel loops in 6 pigs. After 2 h (n = 6), 4 h (n = 6), and 6 h (n = 6), loops were evaluated clinically and by FLER to delineate five regions of interest (ROIs): ischemic zone (ROI 1), presumed viable margins (ROI 2a-2b), and vascularized areas (3a-3b). Capillary lactates were measured to compare clinical vs. FLER assessment. Basal (V 0 ) and maximal (V max) mitochondrial respiration rates were determined according to FLER. RESULTS:Lactates (mmol/L) at clinically identified resection lines were significantly higher when compared to those identified by FLER (2.43 ± 0.95 vs. 1.55 ± 0.33 p = 0.02) after 4 h of ischemia. Lactates at 2 h at ROI 1 were 5.45 ± 2.44 vs. 1.9 ± 0.6 (2a-2b; p < 0.0001) vs. 1.2 ± 0.3 (3a-3b; p < 0.0001). At 4 h, lactates were 4.36 ± 1.32 (ROI 1) vs. 1.83 ± 0.81 (2a-2b; p < 0.0001) vs. 1.35 ± 0.67 (3a-3b; p < 0.0001). At 6 h, lactates were 4.16 ± 2.55 vs. 1.8 ± 1.2 vs. 1.45 ± 0.83 at ROI 1 vs. 2a--2b (p = 0.013) vs. 3a-3b (p = 0.0035). Mean V 0 and V max (pmolO2/second/mg of tissue) were significantly impaired after 4 and 6 h at ROI 1 (V 0 (4h) = 34.83 ± 10.39; V max (4h) = 76.6 ± 29.09; V 0 (6h) = 44.1 ± 12.37 and V max (6h) = 116.1 ± 40.1) when compared to 2a--2b (V 0 (4h) = 67.1 ± 17.47 p = 0.00039; V max (4h) = 146.8 ± 55.47 p = 0.0054; V 0 (6h) = 63.9 ± 28.99 p = 0.03; V max (6h) = 167.2 ± 56.96 p = 0.01). V 0 and V max were significantly higher at 3a-3b. CONCLUSIONS: FLER may identify the future anastomotic site even after repetitive assessments and long-standing bowel ischemia.
Authors: Michael Calonder; Vincent Lepetit; Mustafa Özuysal; Tomasz Trzcinski; Christoph Strecha; Pascal Fua Journal: IEEE Trans Pattern Anal Mach Intell Date: 2011-11-15 Impact factor: 6.226
Authors: Michele Diana; Eric Noll; Pierre Diemunsch; Bernard Dallemagne; Malika A Benahmed; Vincent Agnus; Luc Soler; Brian Barry; Izzie Jacques Namer; Nicolas Demartines; Anne-Laure Charles; Bernard Geny; Jacques Marescaux Journal: Ann Surg Date: 2014-04 Impact factor: 12.969
Authors: Frederic Ris; Roel Hompes; Chris Cunningham; Ian Lindsey; Richard Guy; Oliver Jones; Bruce George; Ronan A Cahill; Neil J Mortensen Journal: Surg Endosc Date: 2014-02-25 Impact factor: 4.584
Authors: Andrea Picchetto; Barbara Seeliger; Stefania La Rocca; Manuel Barberio; Giancarlo D'Ambrosio; Jacques Marescaux; Michele Diana Journal: Chirurg Date: 2019-11 Impact factor: 0.955
Authors: Boris Jansen-Winkeln; N Holfert; H Köhler; Y Moulla; J P Takoh; S M Rabe; M Mehdorn; M Barberio; C Chalopin; T Neumuth; I Gockel Journal: Int J Colorectal Dis Date: 2019-02-02 Impact factor: 2.571
Authors: Nikolaj Nerup; Linea Landgrebe Ring; Rune Broni Strandby; Charlotte Egeland; Morten Bo Søndergaard Svendsen; Jane Preuss Hasselby; Gro Linno Willemoe; Bolette Hartmann; Lars Bo Svendsen; Michael Patrick Achiam Journal: Langenbecks Arch Surg Date: 2018-10-18 Impact factor: 3.445
Authors: Hannes Köhler; Boris Jansen-Winkeln; Marianne Maktabi; Manuel Barberio; Jonathan Takoh; Nico Holfert; Yusef Moulla; Stefan Niebisch; Michele Diana; Thomas Neumuth; Sebastian M Rabe; Claire Chalopin; Andreas Melzer; Ines Gockel Journal: Surg Endosc Date: 2019-01-23 Impact factor: 4.584
Authors: S Hayami; K Matsuda; H Iwamoto; M Ueno; M Kawai; S Hirono; K Okada; M Miyazawa; K Tamura; Y Mitani; Y Kitahata; Y Mizumoto; Hiroki Yamaue Journal: Tech Coloproctol Date: 2019-09-18 Impact factor: 3.781
Authors: Michele Diana; Eric Noll; Anne-Laure Charles; Pierre Diemunsch; Bernard Geny; Yu-Yin Liu; Francesco Marchegiani; Luigi Schiraldi; Vincent Agnus; Veronique Lindner; Lee Swanström; Bernard Dallemagne; Jacques Marescaux Journal: Surg Endosc Date: 2016-06-20 Impact factor: 4.584